Related Experiment Video
Updated: Apr 18, 2026
08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
13.0K
Platelets: the next-generation ovarian cancer biomarker?
Amelia Janiak1, Vahid Afshar-Kharghan2, David G Menter3
1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Trends in Cancer
|April 16, 2026
Abstract
None:
The diagnosis and monitoring of ovarian cancer remain major clinical challenges due to nonspecific symptoms, late-stage detection, and high rates of recurrence. Increasing evidence suggests that circulating platelets reflect tumor presence and activity. Platelet-based molecular and functional signatures may, therefore, represent a promising new class of biomarkers for ovarian cancer.
